Cargando…

Pre-Existing Cross-Reactive Antibody Responses Do Not Significantly Impact Inactivated COVID-19 Vaccine-Induced Neutralization

Recent exposure to seasonal coronaviruses (sCoVs) may stimulate cross-reactive antibody responses against severe acute respiratory syndrome CoV 2 (SARS-CoV-2). However, previous studies have produced divergent results regarding protective or damaging immunity induced by prior sCoV exposure. It remai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jin, Guo, Cheng, Cai, Lin, Liao, Conghui, Yi, Huaimin, Li, Qianlin, Hu, Huan, Deng, Qiang, Lu, Yuying, Guo, Zhongmin, Chen, Zeliang, Lu, Jiahai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640209/ https://www.ncbi.nlm.nih.gov/pubmed/34868035 http://dx.doi.org/10.3389/fimmu.2021.772511

Ejemplares similares

A Multivalent and Thermostable Nanobody Neutralizing SARS-CoV-2 Omicron (B.1.1.529)
por: Lu, Yuying, et al.
Publicado: (2023)

Highly potent multivalent VHH antibodies against Chikungunya isolated from an alpaca naïve phage display library
por: Li, Qianlin, et al.
Publicado: (2022)

T Cell Activating Thermostable Self‐Assembly Nanoscaffold Tailored for Cellular Immunity Antigen Delivery
por: Zhang, Jinsong, et al.
Publicado: (2023)

Factors Associated With Diagnostic Delays in Human Brucellosis in Tongliao City, Inner Mongolia Autonomous Region, China
por: Zhai, Jingbo, et al.
Publicado: (2021)

The Emergence and Spread of Novel SARS-CoV-2 Variants
por: Yi, Huaimin, et al.
Publicado: (2021)

Epidemiologic Characteristics, Transmission Chain, and Risk Factors of Severe Infection of COVID-19 in Tianjin, a Representative Municipality City of China
por: Wang, Jin, et al.
Publicado: (2020)

Do neutral nuclei exist?
por: Hnatowicz, V
Publicado: (1977)

A One Health strategy for emerging infectious diseases based on the COVID-19 outbreak
por: Wu, Qin, et al.
Publicado: (2022)

The worldwide seroprevalence of DENV, CHIKV and ZIKV infection: A systematic review and meta-analysis
por: Li, Zhihui, et al.
Publicado: (2021)

Effects of COVID-19 Non-Pharmacological Interventions on Dengue Infection: A Systematic Review and Meta-Analysis
por: Wu, Qin, et al.
Publicado: (2022)

Driving effect of multiplex factors on human brucellosis in high incidence region, implication for brucellosis based on one health concept
por: Peng, Ruihao, et al.
Publicado: (2022)

Systematic Review and Meta-Analysis on the Association between Outpatient Statins Use and Infectious Disease-Related Mortality
por: Ma, Yu, et al.
Publicado: (2012)

Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVID
por: Peluso, Michael J., et al.
Publicado: (2022)

Challenges in Dengue Vaccines Development: Pre-existing Infections and Cross-Reactivity
por: Izmirly, Abdullah M., et al.
Publicado: (2020)

Prevalence of human alveolar echinococcosis in China: a systematic review and meta-analysis
por: Wang, Xuanzhuo, et al.
Publicado: (2020)

Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction
por: Fitzpatrick, Zachary, et al.
Publicado: (2018)

On the existence of weak neutral currents
por: Albright, C H
Publicado: (1969)

Do metastases arise from pre-existing subpopulations of cancer cells?
por: Weiss, L., et al.
Publicado: (1983)

Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity
por: Henze, Larissa, et al.
Publicado: (2023)

Cross-reactive and pre-existing antibodies to therapeutic antibodies—Effects on treatment and immunogenicity
por: van Schie, Karin A, et al.
Publicado: (2015)

Pre-existing Fc profiles shape the evolution of neutralizing antibody breadth following influenza vaccination
por: Boudreau, Carolyn M., et al.
Publicado: (2023)

Serological reactivity of inactivated SARS-CoV-2 vaccine based on an S-RBD neutralizing antibody assay
por: Zhang, Hui, et al.
Publicado: (2022)

High frequency of pre-existing neutralizing antibody responses in patients with dengue during an outbreak in Central Brazil
por: de Teive e Argolo, Angela Ferreira Lopes, et al.
Publicado: (2016)

Do anomalons exist?
por: Price, P B
Publicado: (1984)

Evidence and implications of pre‐existing humoral cross‐reactive immunity to SARS‐CoV‐2
por: Mveang Nzoghe, Amandine, et al.
Publicado: (2020)

Pre-existing Immunity to Japanese Encephalitis Virus Alters CD4 T Cell Responses to Zika Virus Inactivated Vaccine
por: Lima, Noemia S., et al.
Publicado: (2021)

Solving problems that do not exist and not solving problems that do exist, magnetic personalities included
por: Calisher, Charles H.
Publicado: (2021)

THE REACTIVATION OF HEAT-INACTIVATED HYALURONIDASE
por: Emmart, E. W., et al.
Publicado: (1954)

Do quark stars exist?
Publicado: (1977)

Do Righthanded Neutrinos Exist?
por: Winter, Klaus
Publicado: (2000)

Do Pioneer Cells Exist?
por: Simpson, Matthew J., et al.
Publicado: (2014)

Do Housekeeping Genes Exist?
por: Zhang, Yijuan, et al.
Publicado: (2015)

Why Do Antibiotics Exist?
por: Spagnolo, Fabrizio, et al.
Publicado: (2021)

THE INACTIVATION OF BACTERIOPHAGE BY MERCURY BICHLORIDE; THE REACTIVATION OF BICHLORIDE-INACTIVATED PHAGE
por: Krueger, A. P., et al.
Publicado: (1933)

Investigation of pre-existing reactivity to biotherapeutics can uncover potential immunogenic epitopes and predict immunogenicity risk
por: Bivi, Nicoletta, et al.
Publicado: (2019)

Detection of pre-existing SARS-CoV-2-reactive T cells in unexposed renal transplant patients
por: Anft, Moritz, et al.
Publicado: (2021)

The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
por: Murray, Sam M., et al.
Publicado: (2022)

Do Distinct Groups of Reactively and Proactively Aggressive Children Exist? A Confirmatory Latent Profile Approach
por: van Dijk, Anouk, et al.
Publicado: (2021)

SARS-COV-2-vaccine-inactivated-Sinovac-Biotech/tozinameran: Exacerbation of pre-existing plaque psoriasis: 2 case reports
Publicado: (2022)

Transforming Growth Factor β Neutralization Ameliorates Pre-Existing Hepatic Fibrosis and Reduces Cholangiocarcinoma in Thioacetamide-Treated Rats
por: Ling, Hong, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4n91n338heprcnu5omb8ol7f3g